Cytomos appoints new Commercial and Innovation Officer and Techno-Commercial Adviser: Driving the commercialisation strategy as the company evolves f
23 January 2024: TechBio company, Cytomos (www.cytomotos.com) is pleased to announce the appointment of Dr Fernanda Masri as Chief Commercial and Innovation Officer and Dr Christel Fenge as Techno-Commercial Adviser. In her new role, Fernanda will spearhead Cytomos’ commercialisation strategy, as the company r...
Source: pharmiweb.com